{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "1327632", "DateCompleted": {"Year": "1992", "Month": "10", "Day": "27"}, "DateRevised": {"Year": "2019", "Month": "08", "Day": "19"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0143-5221", "JournalIssue": {"Volume": "83", "Issue": "2", "PubDate": {"Year": "1992", "Month": "Aug"}}, "Title": "Clinical science (London, England : 1979)", "ISOAbbreviation": "Clin Sci (Lond)"}, "ArticleTitle": "Glucocorticoids and blood pressure: a role for the cortisol/cortisone shuttle in the control of vascular tone in man.", "Pagination": {"StartPage": "171", "EndPage": "178", "MedlinePgn": "171-8"}, "Abstract": {"AbstractText": ["1. 11 beta-Hydroxysteroid dehydrogenase converts cortisol to inactive cortisone in man. In distal renal tubules, this inactivation protects mineralocorticoid receptors from cortisol. Congenital 11 beta-hydroxysteroid dehydrogenase deficiency and inhibition of 11 beta-hydroxysteroid dehydrogenase by liquorice or carbenoxolone result in cortisol-dependent hypokalaemia and hypertension. 2. 11 beta-Hydroxysteroid dehydrogenase is expressed in vascular smooth muscle. Both glucocorticoids and mineralocorticoids potentiate vascular responses to noradrenaline. 11 beta-Hydroxysteroid dehydrogenase activity may therefore influence vascular tone. 3. Experiments were performed in healthy subjects with and without 7 days of oral administration of 11 beta-hydroxysteroid dehydrogenase inhibitors (liquorice or carbenoxolone), and in a patient with congenital 11 beta-hydroxysteroid dehydrogenase deficiency. We measured the following parameters: dermal vasoconstriction after topical application of cortisol, forearm blood flow during brachial artery infusion of cortisol or noradrenaline, and blood pressure during systemic infusion of noradrenaline. 4. Cortisol-induced dermal vasoconstriction was increased by liquorice (23 +/- 6 to 52 +/- 7 units; P < 0.04) and in congenital 11 beta-hydroxysteroid dehydrogenase deficiency (87 units). In congenital 11 beta-hydroxysteroid dehydrogenase deficiency intraarterial infusion of cortisol caused vasoconstriction (20% reduction in blood flow in the infused arm) and accentuated the response to application of lower-body negative pressure, which stimulates sympathetically mediated vasoconstriction (35% reduction). However, intra-arterial infusion of cortisol had no effect in healthy subjects either with or without administration of liquorice. 5. Carbenoxolone potentiated both noradrenaline induced forearm vasoconstriction (P < 0.01) and pressor response (P < 0.001). 6. We conclude that 11 beta-hydroxysteroid dehydrogenase modulates the access of cortisol to vascular receptors and thereby influences vascular sensitivity to noradrenaline.(ABSTRACT TRUNCATED AT 250 WORDS)"]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "University of Edinburgh, Department of Medicine, Western General Hospital, Scotland, U.K."}], "LastName": "Walker", "ForeName": "B R", "Initials": "BR"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Connacher", "ForeName": "A A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Webb", "ForeName": "D J", "Initials": "DJ"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Edwards", "ForeName": "C R", "Initials": "CR"}], "PublicationTypeList": ["Case Reports", "Clinical Trial", "Comparative Study", "Controlled Clinical Trial", "Journal Article", "Randomized Controlled Trial", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Clin Sci (Lond)", "NlmUniqueID": "7905731", "ISSNLinking": "0143-5221"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Glucocorticoids"}, {"RegistryNumber": "EC 1.1.-", "NameOfSubstance": "Hydroxysteroid Dehydrogenases"}, {"RegistryNumber": "EC 1.1.1.146", "NameOfSubstance": "11-beta-Hydroxysteroid Dehydrogenases"}, {"RegistryNumber": "MM6384NG73", "NameOfSubstance": "Carbenoxolone"}, {"RegistryNumber": "V27W9254FZ", "NameOfSubstance": "Cortisone"}, {"RegistryNumber": "WI4X0X7BPJ", "NameOfSubstance": "Hydrocortisone"}, {"RegistryNumber": "X4W3ENH1CV", "NameOfSubstance": "Norepinephrine"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "11-beta-Hydroxysteroid Dehydrogenases"}, {"QualifierName": [], "DescriptorName": "Adult"}, {"QualifierName": ["physiology"], "DescriptorName": "Blood Pressure"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Carbenoxolone"}, {"QualifierName": ["physiology"], "DescriptorName": "Cortisone"}, {"QualifierName": [], "DescriptorName": "Double-Blind Method"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["physiology"], "DescriptorName": "Glucocorticoids"}, {"QualifierName": [], "DescriptorName": "Glycyrrhiza"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pharmacology", "physiology"], "DescriptorName": "Hydrocortisone"}, {"QualifierName": ["antagonists & inhibitors", "deficiency"], "DescriptorName": "Hydroxysteroid Dehydrogenases"}, {"QualifierName": ["drug effects"], "DescriptorName": "Kidney"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["drug effects"], "DescriptorName": "Muscle, Smooth, Vascular"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Norepinephrine"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["blood supply"], "DescriptorName": "Skin"}, {"QualifierName": ["drug effects"], "DescriptorName": "Vasoconstriction"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1992", "Month": "8", "Day": "1"}, {"Year": "1992", "Month": "8", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1992", "Month": "8", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["1327632", "10.1042/cs0830171"]}}]}